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An emv-14-derived, replication-competent ecotropic murine leukemia virus [MuLV], designated AK7, was previously cloned
from the AKXL-5 recombinant inbred mouse strain and partially characterized. While genetically encoding for an envelope-
derived immunodominant CTL epitope [KSPWFTTL] located in the transmembrane region of p15TM, this virus, unlike the
emv-11-derived virus AKR623, fails to be efficiently recognized by AKR/Gross MuLV-specific cytotoxic T lymphocytes [CTL].
AK7 thus provides the opportunity to study the role of retroviral sequence variations that are located outside of the
immunodominant epitope as a mechanism of escape from CTL-mediated immune survellience. In an attempt to identify
which region[s] of the AK7 genome could account for its ability to evade efficient recognition by AKR/Gross MuLV-specific
CTL, we have constructed recombinant murine retroviruses. The direct influence of a sequence variation twelve amino
acids N-terminal to KSPWFTTL was explored with the use of chimeric viruses and determined not to significantly impair
the presentation of KSPWFTTL to AKR/Gross MuLV-specific CTL. The long terminal repeat [LTR] derived from the AK7
virus, which possesses only one copy of the 99-base pair transcriptional enhancer in the U3 region, in contrast to AKR623
that possesses two copies of the tandem direct repeat enhancers, was also analyzed for its influence on the presentation
of KSPWFTTL. Interestingly, our data indicate that the enhancer region derived from AK7 negatively influences the presenta-
tion of KSPWFTTL in the context of a recombinant AKR623 virus. q 1997 Academic Press
INTRODUCTION brane region [TM] of the envelope protein in almost all
emv studied [Coppola et al., 1995] and many MCF MuLV
AKR [H-2k] mice have a high incidence of spontane-
[Sijts et al., 1994; Coppola and Green, 1994].
ously occuring leukemias believed to be proximally in-
Three highly related endogenous emv proviruses
duced by thymotropic mink cell focus-inducing [MCF]
found in AKR mice, emv-11, emv-13, and emv-14, were
retroviruses of the AKR/Gross type. MCF retroviruses are
previously studied. AKXL recombinant inbred mice, gen-
dualtropic, capable of infecting both murine as well as
erated from the AKR and C57L progenitor strains, allowed
xenogeneic cells, and are formed from the recombination
for the independent segregation of these endogenous
of expressed endogenous ecotropic murine leukemia vi-
emv [Steffen et al., 1982]. Interestingly, splenocytes from
ruses [emv] with other endogenous xenotropic and poly-
emv-14 positive AKXL-5 mice failed to stimulate an AKR/
tropic murine leukemia viral sequences [Hartley et al.,
Gross MuLV-specific CTL response in responder C57BL/
1977; Stoye et al., 1991; Elder et al., 1977; Chattopadhyay
6 mice while splenocytes from emv-11-positive AKXL
et al., 1981; Cloyd et al., 1985; Khan, 1984]. The genera- mice successfully stimulated the response [Green and
tion of these leukemogenic MCF retroviruses is thus de- Graziano, 1986]. When AKXL mice were used as the re-
pendent upon the expression of ecotropic MuLV. C57BL/ sponders to generate an AKR/Gross MuLV-specific CTL
6 [H-2b] mice have a much lower incidence of spontane- response, a clear pattern emerged where emv-14 nega-
ously occuring thymic leukemias and have been shown tive AKXL-29 mice could mount a full AKR/Gross MuLV-
to generate vigorous H-2Kb-restricted CTL responses specific CTL response, while emv-14-positive AKXL-5
against tumors induced by the AKR/Gross MuLV [Green mice were only partially responsive [Green and Rich,
et al., 1979, 1980]. In contrast, AKR mice were unable to 1988]. Furthermore, AKR/Gross MuLV-specific CTL-rec-
mount H-2k restricted anti-AKR/Gross MuLV CTL re- ognized SC.Kb cells infected with virus isolated from emv-
sponses [Green, 1984]. The C57BL/6-derived T lympho- 11-positive AKXL-21 mice very efficiently. In contrast,
cytes, designated as AKR/Gross MuLV-specific CTL, are SC.Kb cells infected from virus derived from emv-14-posi-
directed specifically against an immunodominant T cell tive AKXL-5 mice were poorly recognized [White et al.,
epitope [KSPWFTTL] [White et al., 1994a; Sijts et al., 1994; 1990]. Subsequent molecular cloning of the ecotropic
Green and Smith, 1996] located in the p15 transmem- AK7 MuLV, derived from emv-14-positive AKXL-5 mice,
led to the observation that AK7-infected cells were ineffi-
ciently recognized by AKR/Gross MuLV-specific CTL, in1 To whom correspondence and reprint requests should be ad-
dressed. Fax: [603] 650-6223. E-mail: William.R.Green@Dartmouth.Edu. contrast to cells infected by the emv-11-derived molecu-
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lar clone AKR623 which were very efficiently recognized Viruses
[White et al., 1993]. These findings were curious since
The BM5 ecotropic TM 122E/134K and BM5 ecotropicboth AK7 and AKR623 genetically encoded for the immu-
TM 122K/134K retroviral recombinants were constructednodominant KSPWFTTL epitope at TM134–141. Recogni-
by excising the 846-bp BssHII/XbaI fragment from thetion of AK7 MuLV infected cells by AKR/Gross MuLV-
parental plasmid pBM5 eco and inserting it into thespecific CTL was dramatically improved, however, when
BssHII/XbaI site in the polylinker region of the plasmidAK7-infected cells were exogenously pulsed with the
pNEB193 [New England Biolabs] resulting in the plasmidsynthetic peptide KSPWFTTL, suggesting that there was
designated as pNEB-RS1. The 3537-bp XbaI/BstXI frag-a defect in the presentation of KSPWFTTL that should
ment from pNEB-RS1 was then ligated to the 260-bpbe endogenously produced from this virus [White et al.,
XbaI/BstXI fragment derived from either the pAKR623 or1994b]. Partial sequencing [H. D. White; unpublished ob-
pAK7 plasmids resulting in the plasmids pNEB-RS1 [623]servations] of the AK7 retrovirus has elucidated two sig-
or pNEB-RS1 [7], respectively. The 846-bp BssHII/XbaInificant differences, when compared to the efficiently rec-
fragment from either pNEB-RS1 [623] or pNEB-RS1 [7]ognized AKR623 virus, that could potentially account for
was then inserted into the 12-kb BssHII/XbaI fragmenta negative influence on KSPWFTTL presentation. In this
from pBM5 eco resulting in the plasmids pBM5 eco TMreport, we investigated the possibility that either a flank-
122E/134K and pBM5 eco TM 122K/134K. The resultinging sequence variation located twleve amino acids N-
pBM5 eco TM 122E/134K and pBM5 eco TM 122K/134Kterminal to KSPWFTTL and/or a distal variation located
constructs were then introduced into SC-1 cells by cal-in the U3 region of the long terminal repeat [LTR] en-
cium-phosphate-mediated transfection.coded by the AK7 MuLV is responsible for the failure of
The AKR623/7 LTR viral chimera was constructed byAK7 virally infected cells to be efficiently recognized by
excising the 388-bp BssHII fragment from pAK7, whichAKR/Gross MuLV-specific CTL.
contains only a single copy enhancer, and ligating it to
the pAKR623-derived 10540-bp BssHII fragment, from
MATERIALS AND METHODS which the tandem direct repeat sequences were already
removed. The resulting pAKR623/7 LTR construct was
Cell lines then introduced into SC-1 cells by calcium-phosphate-
mediated cotransfection with the plasmid pSV2His. Su-The SC-1 cell line is a continuous fibroblast line from a
pernatants from SC-1 cells transfected with pBM5ecoferal mouse embryo and is cultured in Dulbecco modified
TM 122E/134K, pBM5 eco TM 122K/134K, or AKR 623/7Eagle medium supplemented with 5% fetal bovine serum,
LTR were then collected, briefly spun down, and filtered2 mM L-glutamine, 33 mg gentamycin per milliliter, 30 mg
before using to infect SC.Kb cells that had been culturedof penicillin per milliliter, and 20 mg of streptomycin per
in the presence of polybrene for at least 12 hr. Infectedmilliliter. The MHC class I H-2Kb gene was introduced
SC.Kb cells were then subjected to FACS analysis usinginto SC-1 giving rise to SC.Kb as previously described
the antiviral-specific monoclonal antibodies 24-8, a mu-[White et al., 1990]. B.GV and E?G2 are H-2b Gross virus
rine IgG2a mAb specific for emv gp70, and 548 which iscell surface antigen [GCSA]-positive tumor cell lines de-
a murine IgG2b mAb specific for the p12 [gag] antigen.rived from a BALB.B congenic and a C57BL/6 mouse,
Recombinant vaccinia virus encoding for H-2Kb [vac-respectively, both induced with the Gross virus passage
cinia Kb] was kindly provided by Dr. Jack Bennink [NIAID/A MuLV. AKR.H-2b SL1 is a GCSA-positive tumor cell line
NIH] and was used to infect SC-1, SC-1 BM5 ecotropicderived from a spontaneous leukemia from an AKR.H-2b
TM 122E/134K, and SC-1 BM5 ecotropic TM 122K/134Kcongenic mouse. YAC-1 [YAC] is an H-2a tumor cell line
cells at a multiplicity of infection [m.o.i.] of 10:1 for 1that is used here as a highly natural killer [NK]-sensitive
hr in BSS/BSA. Vaccinia virus-infected cells were thentarget cell. The B.GV, E?G2, YAC, and AKR.H-2b SL1
incubated in DMEM media containing 5% fetal bovinetumor cell lines were grown in RPMI supplemented with
serum for 4 hr before conducting the CTL assay.5% fetal bovine serum, 2 mM L-glutamate, 33 mg genta-
mycin per milliliter, 50 mM 2-mercaptoethanol, 30 mg of RT-PCR and DNA sequencing
penicillin per milliliter, and 20 mg of streptomycin per
milliliter. EL4[S] is a C57BL/6-derived T cell lymphoma, The pBM5 eco TM 122E/134K, pBM5 eco TM 122K/134K,
and pAKR623/7 LTR generated plasmid constructs wereand EG7 is a clone of EL4 that has been transfected with
an ovalbumin [OVA] cDNA [Moore et al., 1988]. RF33.70 is sequenced by thermal cycle dideoxy DNA sequencing
[New England Biolabs] using the M13/pUC [040] oligonu-a C57BL/6-derived anti-OVA-specific T-T cell hybridoma
[Rock et al., 1990]. The EG7 and RF33.70 cell lines were cleotide 5*-GTTTTCCCAGTCACGAC-3* and the M13/pUC
[048] oligonucleotide 5*-AGCGGATAACAATTTCACACA-grown in either DMEM or RPMI, respectively, both sup-
plemented with 10% fetal bovine serum, 33 mg genta- GGA-3* to confirm TM122E-TM134K, TM122K-TM134K, and
the enhancer region of the LTR, respectively. The SC.Kbmycin per milliliter, 30 mg of penicillin per milliliter, and
20 mg of streptomycin per milliliter. All cell lines were BM5 eco TM 122E/134K- and SC.Kb BM5 eco TM 122K/
134K-infected cell lines were confirmed for the TM122E-maintained at 377 in a 5% CO2 atmosphere.
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TM134K and TM122K-TM134K regions, respectively, by RT- a murine IgM antibody [Ozato et al., 1981], and HB158
[Pharmingen], an affinity purified mouse IgG2a mAb werePCR sequencing using Taq polymerase [Perkin–Elmer].
PCR was conducted on extracted RNA [Sigma] reverse also used.
transcribed into cDNA [Boehringer-Mannheim] with PCR
Flow cytometric analysisconditions set at 957 1 min, 557 1 min, 727 2 min for 25
cycles, and directly sequencing the 222-bp PCR product Cell surface antigen expression was measured by indi-
using the oligonucleotides 623/7499 5*-GTACGGGATAGC- rect immunofluorescence. Then 1 1 106 cells washed
ATGGCCAAACTTAGAGAA-3* and 623/7694 5*-CTACCG- with staining medium consisting of RPMI 1640 containing
AAATCCTGTCTTTGATAAACTG-3*. The SC.Kb 623/7 LTR 0.2 % [wt/vol] bovine serum albumin [Sigma Chemical]
cell line was confirmed for the AK7-derived enhancer region were incubated with the appropriately diluted mAb for 1
by RT-PCR and direct sequencing using the oligonucleo- hr at 47. The samples were washed twice in staining
tides LTR[/] 5*-GCAAGGCATGGGAAAATACCAGAGCTG- medium and then treated with the appropriately diluted
ATG-3* and LTR[0] 5*-TCCCCGGTCATCTGGGGAACC- FITC-conjugated secondary antibody [goat anti-mouse or
TTGAGACAG-3*. The oligonucleotides 623/7499, 623/7694, goat anti-rat immunoglobulin]. Cells were incubated at
LTR[/], and LTR[0] were synthesized at the Dartmouth 47 for 1 hr with the secondary antibody and then washed
College Molecular Biology Core Facility. once with staining medium before fixing the cells in 1%
parafomaldehyde. Background fluorescence values were
Assay for cell-mediated cytotoxicitiy
determined with the following irrelevant monoclonal anti-
bodies used as isotype controls: OKT8 [CRL 8014, murineAKR/Gross MuLV-specific CTL were generated by im-
IgG2a] for 24-8, 9E8 and HB158; OKM1 [CRL 8026, murinemunizing C57BL/6 male mice with 2 1 106 B.GV cells
IgG2b] for 19VIII-E8; 35-12 [murine IgM] for HB41; andi.p. Approximately 10 days later, the spleen cells were
purified rat IgG2a for 35/299. Flow cytometry analysisharvested and cultured with irradiated [8000 rads] E?G2
was performed on a FACScan [Becton–Dickinson immu-or AKR.H-2b SL1 stimulator cells at a responder to stimu-
nocytometry systems] set on a linear amplifier.lator ratio of 40:1 or with stimulating KSPWFTTL peptide
at 10 mg/ml at 377 in a 5% CO2 atmosphere. AntiH-2
b
IL-2 biosassyallogeneic CTL were generated by culturing BALB/c
splenocytes with irradiated [2000 rads] C57BL/6 spleno- The IL-2 content in stimulated T cell hybridoma culture
cytes at a responder to stimulator ratio of 2:1. After 6 supernatants was measured in a quantitative bioassay
days in culture, effector cells were harvested and incu- with CTLL-2 indicator cells [Gillis et al., 1978]. Hybridoma
bated with 51Cr- labeled target cells at various effector- cultures were prepared with 105 RF33.70 cells in the
to-target [E:T] ratios at 377 in a 5% CO2 atmosphere for presence or absence of various antigen presenting cells
6 hr in the case for fibroblast targets or 4 hr for tumor [APC] in 200 ml media in flat bottom microtiter wells in
targets. NK-sensitive YAC target cells were included in duplicate. After a 20-hr incubation at 377, serial dilutions
all CTL assays and always observed to lyse at values of the stimulated versus control hybridoma supernatants
less than 2%. Percentage of specific lysis was calculated were tested for their ability to support the proliferation
according to the following formula: {[A 0 B] 4 C} 1 100 of the highly IL-2-sensitive CTLL-2 cell line.
where A  51Cr released from target cells incubated with
CTL, B  51Cr released by target cells incubated alone, RESULTS
and C  total freeze–thaw releasable 51Cr [approxi-
TM122K does not appear to negatively influence themately 80%]. Lytic unit values were defined as the num-
presentation of the TM134-141 CTL epitopeber of effectors required for 30% lysis and were deter-
[KSPWFTTL] in SC.Kb cellsmined by plotting percentage of lysis values versus the
log of the effector cell number and expressed as the
To identify which region[s] of the AK7 MuLV genome
number of lytic units per 106 effector cells.
could account for its ability to evade efficient recognition
by AKR/Gross MuLV-specific CTL, known sequences ofAntibodies
the AK7 MuLV were compared to the very efficiently rec-
ognized AKR623 MuLV since these are two very similarTwo monoclonal antibodies [mAb] specific for gp70
were used: 35/299, a rat IgG2a mAb specific for ecotropic viruses, having originated from a common primordial emv
[Steffen et al., 1982]. Sequencing in the vicinity of KSP-gp70 [Pinter et al, 1982]; and 24-8, a murine IgG2a mAb
with a broad specificity for the gp70-p15E-associated WFTTL in the p15TM region of the envelope gene re-
vealed that AK7 encodes for a predicted lysine at positioncomplex [Portis et al., 1982]. Two mAbs specific for
p15TM were also used: 9E8, an ascites-derived murine TM122 instead of the glutamic acid residue found in the
AKR623, SL3-3, and MCF247 viruses that are representa-IgG2a mAb specific for the p15Ea determinant [Lostrom
et al., 1979]; and 19VIII-E8, an ascites-derived murine tive of viruses efficiently recognized by AKR/Gross MuLV-
specific CTL [Coppola and Green, 1994; White et al.,IgG2b mAb specific for the p15Eb determinant [Lostrom
et al., 1979]. The H-2Kb-specific mAb HB41 [28-13-3s], 1993] [Fig. 1A].
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FIG. 1. Comparative sequences of the AKR623 [Herr, 1984], SL3-3 [Lenz], MCF247 [Kelly et al., 1983], and AK7 [this study] retroviruses. A represents
amino acid sequences corresponding to TM117–149 found within the p15TM region of the envelope gene. The immunodominant KSPWFTTL peptide
is underlined. The nucleotides GAA found in AKR623, SL3-3, and MCF247 encode for the negatively charged glutamate while the AK7-derived AAA
sequence encode for a positively charged lysine residue at amino acid position 122. The data documenting the relative susceptibilities of cells
infected by these retroviruses to AKR/Gross MuLV-specific CTL was derived from published studies [Coppola and Green, 1994; White et al., 1993].
The determination for SL3-3 was done with NB-tropic SL3-3 [Coppola et al., 1996; Thomas et al., 1993]. B illustrates the nucleotide sequence of a
single copy of the transcriptional enhancer found in the U3 region of the LTR. The single copy of the AK7 transcriptional enhancer is identical to
either of the two AKR623 tandem direct repeats with the exception of a T insertion followed immediately by a G r A substituion. (GenBank Accession
No. AF019257).
To explore the possibility that CTL epitope processing but with either a glutamate or a lysine, respectively, at posi-
tion TM122. Positioning the KSPWFTTL epitope along withand/or presentation might be affected by this nonconserva-
tive change, we examined this sequence variation for its the corresponding TM122-encoded amino acid in a common
viral backbone in this fashion thus allowed us to directlyspecific influence on the presentation of KSPWFTTL. Two
viral chimeras were constructed utilizing the BM5 ecotropic study the influence of this flanking sequence variation on the
presentation of KSPWFTTL. SC-1 fibroblast cells expressingvirus as the viral backbone [Fig. 2]. The highly infectious
BM5 ecotropic virus is normally not recognized by H-2Kb- either of the two chimeric retroviruses were then assayed
at the target level against H-2Kb-restricted AKR/Gross MuLV-restricted AKR/Gross MuLV-specific CTL since it encodes
for RSPWFTTL instead of KSPWFTTL at TM134-141 [Coppola specific CTL, derived from C57BL/6 mice by in vivo priming
and secondary in vitro stimulation with MHC compatibleet al., 1995]. Two recombinant retroviruses, BM5 ecotropic
TM 122E/134K and BM5 ecotropic TM 122K/134K, were gen- AKR/Gross MuLV-induced tumor cells, as demonstrated pre-
viously in our lab [Green, 1982]. To introduce the MHC re-erated so that they both encoded for the KSPWFTTL epitope,
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FIG. 2. Construction strategy of the BM5 ecotropic TM 122E/134K and BM5 ecotropic TM 122K/134K viral chimeras used in this study as detailed
under Materials and Methods. The steps leading to the formation of pNEB-RS1 have not been depicted for clarity.
striction element into these cells, recombinant vaccinia virus iment was performed three times with similar results. Al-
though the data displayed in Figs. 3 and 4 suggest thatencoding for H-2Kb was used to infect the SC-1 cells con-
the BM5 ecotropic TM 122K/134K viral chimera may betaining either chimeric retrovirus.
slightly more efficiently recognized than the BM5 ecotropicFigure 3 shows that vaccinia virus Kb-infected target
TM 122E/134K viral chimera, repeated experiments havecells containing the BM5 ecotropic TM 122K/134K viral
indicated that this small difference was not a consistentchimera, which harbors the TM122K variation derived from
and significant result. RT-PCR was performed from thethe AK7 MuLV, were recognized with a similar degree of
RNA extracted from these two infected SC.Kb cell lines,efficiency as the BM5 ecotropic TM 122E/134K viral chi-
and direct sequencing of the PCR products confirmedmera which contains the normal glutamate at TM122 de-
the identity of both chimeric retroviruses. These resultsrived from the AKR623 virus. This experiment was per-
collectively suggested that the flanking amino acid se-formed three times with similar results. To further validate
quence variation from glutamate to lysine found at positionthis finding and demonstrate that these results were not
TM122 in the AK7 MuLV does not negatively impact thedue to an artifact, such as a crossreactive epitope intro-
final presentation of the immunodominant KSPWFTTL epi-duced by the vaccinia virus infection, or were influenced
tope to H-2Kb-restricted antiviral CTL.by a limitation in the Kb expression levels that could be
achieved by the recombinant vaccinia virus infection, the
The AK7-derived transcriptional enhancer partiallypreviously characterized SC.Kb cell line was alternatively
influences the ability of AKR623/7 LTR-infected cellsused at the target level since it endogenously produces
to be recognizedthe appropriate restriction element. As Fig. 4 demon-
strates, SC.Kb target cells, whether infected by the BM5 Another region of the AK7 MuLV genome that could
ecotropic TM 122K/134K or the BM5 ecotropic TM 122E/ have potentially accounted for the inefficient recognition
134K viral chimera, were also recognized with similar effi- of AK7 MuLV-infected cells by AKR/Gross MuLV-specific
CTL was its long terminal repeat [LTR]. It was previouslyciencies by the AKR/Gross MuLV-specific CTL. This exper-
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FIG. 3. TM122K does not negatively influence TM134–141 processing and presentation in vaccinia Kb infected SC-1 cells. SC-1 cells harboring either
the BM5 eco TM 122E/134K or the BM5 eco TM 122K/134K chimeric virus were infected with the recombinant vaccinia Kb virus at a multiplicity of
infection of 10:1 5 hr before the B.GV-primed and E?G2 tumor-stimulated AKR/Gross MuLV-specific CTL were added at an effector to target ratio of
100:1 in a standard chromium release assay as described under Materials and Methods. Target cell spontaneous release values ranged from 6 to 9%.
demonstrated by RFLP analysis that the AK7 retrovirus of AKR623 or AK7 infected cells, based either on exami-
nation of specific lysis values or on lytic unit calculationscontains only a single copy of the 99-bp transcriptional
enhancer found in the U3 region of its LTR [White et al., [legend to Fig. 5]. This experiment was conducted a total
of four times with Fig. 5A representing one such experi-1993], while in contrast, the AKR623 retrovirus contains
two copies of the enhancer, otherwise known as the tan- ment and Fig. 5B depicting the average of the three other
experiments. Although there was some variation in thedem direct repeat sequences. Other than this difference,
sequencing of this region has revealed that AK7 has a degree of recognition by antiviral CTL of cells infected
by the AKR623/7 LTR chimeric virus, relative to AKR623-highly homologous enhancer sequence when compared
to AKR623 [this study]. In fact, the AK7 enhancer sequence or AK7-infected SC.Kb cells, SC.Kb cells infected by the
AKR623/7 LTR chimera were never as poorly recognizedonly differs from the AKR623 sequence by two nucleotides
as depicted in Fig. 1B. This difference in sequence al- as AK7-infected cells, indicating the existence of other
AK7 sequences that interfered with the functional presen-lowed for the easy and definitive identification of the two
different LTRs even if a spontaneous tandem duplication tation of peptide 12. RT-PCR was performed from the
RNA extracted from the AKR623/7 LTR-infected SC.Kb cellof the AK7 LTR direct repeat had occured.
In order to explore what influence the AK7 retroviral line and direct sequencing of the PCR product verified
the presence of only the AK7-derived enhancer. TheseLTR had on the presentation of KSPWFTTL, a viral chi-
mera was constructed in the context of the AKR623 retro- data thus collectively suggest that the transcriptional en-
hancer derived from AK7 played an important, but notvirus. The AKR623/7 LTR recombinant retrovirus has its
LTR derived from AKR623, with the exception that the the only, negative role in the presentation of KSPWFTTL.
Retroviral LTR enhancer regions are generally consid-tandem direct repeat sequences were excised and re-
placed with the single copy enhancer sequence derived ered to function as a positive regulator of viral transcrip-
tion. As Fig. 1B depicts, the AK7 retrovirus contains onlyfrom the AK7 viral LTR. As demonstrated in Figs. 5A and
5B, SC.Kb cells infected with the AKR623/7 LTR retroviral a single copy of the 99-bp transcriptional enhancer found
in the U3 region of its LTR while the AKR623 virus pos-chimera were recognized at levels intermediate to that
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FIG. 4. TM122K does not negatively influence TM134–141 CTL epitope processing and presentation in SC.Kb cells. SC.Kb cells infected with either
the BM5 Eco TM 122E/134K or the BM5 Eco TM 122K/134K chimeric retrovirus were used as target cells in a standard chromium release assay with
B.GV-primed and AKR.H-2b.SL1 tumor-stimulated AKR/Gross MuLV-specific CTL. Target cell spontaneous release values ranged from 15 to 23%.
sesses two copies of the enhancer. To address whether ther AKR623 [emv-11 derived] or AK7 [emv-14 derived]
and expressing similar steady state levels of retroviralviral env gene expression was equivalent at the protein
antigens were compared, AKR/Gross MuLV-specific CTLlevel for AKR623 versus AK7-infected SC.Kb cells, flow
recognized AKR623-infected cells much more efficientlycytometry was utilized to quantitate gp70 and p15TM. As
than AK7-infected cells [White et al., 1993]. Recognitiondemonstrated in Fig. 6, the data for mAb 35/299, which
of AK7 virally infected SC.Kb cells by AKR/Gross MuLV-detects gp70; as well as for 9E8, which is specific for
specific CTL was dramatically improved when these cellsp15TM; show that both gp70 and p15TM are expressed
were exogenously pulsed with the synthetic KSPWFTTLat either roughly equivalent or greater levels in AK7-in-
peptide representing the immunodominant CTL epitopefected SC.Kb cells in comparison to AKR623-infected
[White et al., 1994b]. These findings were intriguing sinceSC.Kb cells. The mAb 24-8, which recognizes the viral
AK7 genetically encoded for KSPWFTTL [Fig. 1], sug-gp70-p15E-associated complex, and the mAb 19VIII-E8,
gesting that a defect in KSPWFTTL processing and pre-specific for p15TM, were also used to confirm that SC.Kb
sentation was occuring. Allogeneic CTL directed againstcells infected with AK7 expressed at least as much cell
H-2b had also been used to demonstrate that the failuresurface gp70 and p15TM as AKR623 infected SC.Kb cells
of emv-14-infected SC.Kb cells to be efficiently recognized[data not shown]. Thus, the inefficient recognition of AK7-
by AKR/Gross MuLV-specific CTL was not due to theinfected SC.Kb cells by AKR/Gross MuLV-specific CTL
downregulation of MHC class I [White et al., 1990].that was consistently observed previously [White et al.,
One alternative mechanism that we address in the1993 and 1994b] and here in Figs. 5A and 5B was not
present study is the influence of sequence variationsdue to lower levels of expression of either the envelope
encoded by AK7 that may affect KSPWFTTL processingprotein or more specifically, p15TM, within which peptide
and/or presentation. CTL recognize antigens as short12 is located. Figure 6 also demonstrates that the cell
peptides bound to the MHC class I molecule, thus impos-surface expression levels for H-2Kb, the restriction ele-
ing the requirement that viral proteins be proteolyticallyment for peptide 12 presentation, were essentially the
processed before they can be presented to T cells. Assame in either AKR623 or AK7 infected SC.Kb cells. Simi-
a result, not only are the recently defined MHC class Ilar results were also obtained with a second H-2Kb spe-
allele-specific motifs important [Rammensee et al., 1993cific mAb [HB158, data not shown].
and 1995], but the cleavage preferences of the proteaso-
DISCUSSION mal complex could potentially affect the availability of
In summary, previous experiments have demonstrated peptides either quantitatively and/or qualitatively [Eggers
et al., 1995; Niedermann et al., 1995]. The specific mecha-that when SC.Kb fibroblast target cells, infected with ei-
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nism of the proteolytic machinery that cleaves endoge- the display of KSPWFTTL to H-2Kb-restricted CTL is not
influenced by the specific TM122K variation.nously synthesized viral proteins into smaller peptides
is incompletely understood, and flanking sequences may The other prominent disparity between the AK7 and
AKR623 viruses resides within the U3 region of the LTR.hinder the creation of immunogenic peptides, such as
by making the epitopes more sensitive to proteolysis, The U3 region of the retroviral LTR contains the transcrip-
tional promoter and enhancer elements that are requiredresulting in smaller nonantigenic peptides [Niedermann
et al., 1995; Ossendorp et al., 1996]. In addition to the for viral gene expression. The transcriptional enhancer re-
gion found in the murine retroviral LTR is usually observedpossibility of affecting proteolysis of the viral proteins,
flanking sequence variations with respect to the immuno- as a direct repeat of 50 to 100 nucleotides and contains
binding sites for various cellular transcription factorsdominant KSPWFTTL could also influence the effective-
ness of KSPWFTTL containing peptides to be translo- [Speck and Baltimore, 1987]. Studies on the pathogenesis
of murine retroviruses have demonstrated that a crucialcated, via the TAP transporters, into the lumen of the ER
for the subsequent binding to class I [Neisig et al., 1995]. determinant of viral leukemogenicity is the transcriptional
enhancer found within the U3 region of the LTR [Speck etMoreover, when KSPWFTTL containing peptides are
translocated into the ER, the possibility exists that flank- al., 1990; DesGroseillers and Jolicoeur, 1984; Morrison et
al., 1995]. Our lab has previously characterized the AK7ing sequences may affect the ability to trim the peptides
to the appropriate size for MHC class I binding. The MuLV as having only one copy of the transciptional en-
hancer found in the U3 region as depicted in Fig. 1B [Whiteprecise role of flanking sequences in MHC class I anti-
gen presentation, however, is not fully understood and et al., 1993]. Interestingly, the AK7 virus differs in its single
enhancer copy from AKR623 by two nucleotides [Fig. 1B]remains controversial. While evidence has been reported
demonstrating that flanking sequences can influence the within the binding site for the transcription factor TEF-I
[Lovmand et al., 1990; Davidson et al., 1988]. In this study,presentation of MHC class I-restricted peptides, other
cases exist where no influence is observed as well [Eg- we have constructed a chimeric AKR623 retrovirus where
we replaced its normal tandem direct repeat sequencesger et al., 1995; Niedermann et al., 1995; Ossendorp et
al., 1996; Neisig et al., 1995; Eisenlohr et al., 1992; Koup, with the single enhancer copy derived from the AK7 MuLV.
If AK7-infected cells are inefficiently recognized by AKR/1994; Del Val et al., 1991; Hahn et al., 1991 and 1992; Fu
et al., 1993; Mylin et al., 1995; Bergmann et al., 1994 and Gross MuLV-specific CTL solely due to the single copy of
the transcriptional enhancer, then it would be predicted1996; Shastri et al., 1995; Couillin et al., 1994; Chimini et
al., 1989; Yellen-Shaw et al., 1997a and 1997b]. that the AKR623/7 LTR chimeric virus would similarly be
inefficiently recognzied. Testing SC.Kb cells infected withWe approached these possibilities by constructing ret-
roviral chimeras. To directly assess the influence of the this chimeric retrovirus against AKR/Gross MuLV-specific
CTL has demonstrated that recognition by AKR/Grossonly proximally located flanking sequence variation en-
coded by AK7, we positioned a small region containing MuLV-specific CTL occurs at levels intermediate to that of
AKR623 and AK7-infected SC.Kb cells [Figs. 5A and 5B].the KSPWFTTL epitope along with the corresponding ly-
sine or glutamate flanking sequence variation [Fig. 1], This experiment was performed four times and included
the use of allogeneic CTL directed against H-2b as aninto a common viral backbone [BM5 ecotropic]. In the
data presented in this report, we find that the existence internal control for Kb expression levels [data not shown].
While variable susceptibilities to anti-H-2b allogeneic CTLof a positively charged lysine at position TM122, as op-
posed to a negatively charged glutamate, 12 amino acids were sometimes observed, even when normalizing for the
differential levels of allogeneic CTL susceptibilites, theN-terminal to KSPWFTTL in AK7 does not negatively im-
pact the presentation of the immunodominat KSPWFTTL. overall interpretation that AKR623/7 LTR-infected SC.Kb
cells are at lysis levels intermediate to that of AKR623-This direct comparison was performed both in vaccinia
Kb-infected SC-1 cells and in SC.Kb cells, the latter in and AK7-infected cells by AKR/Gross MuLV-specific CTL
remains consistent. When H-2Kb expression levels werewhich there should have been no limitation of expression
of the Kb restricting element or complicating factors due monitored by flow cytometry, it was found that both
AKR623- and AK7-infected SC.Kb cells expressed H-2Kb atto vaccinia virus infection. Our findings thus suggest that
the processing and presentation machinery involved in essentially equivalent levels [Fig. 6].
FIG. 5. The AKR623/7 LTR chimeric virus is recognized by anti-AKR/Gross MuLV-specific CTL at a level intermediate to that of SC.Kb cells infected
by AKR623 or AK7 MuLV. The AKR623/7 LTR viral chimera was used here to study the role of the AK7-derived enhancer on KSPWFTTL presentation.
The AKR623/7 LTR viral chimera is essentially the AKR623 virus with its enhancer regions replaced with the single enhancer region derived from
the AK7 LTR as detailed under Materials and Methods. SC.Kb cells infected with the AKR623/7 LTR chimeric retrovirus were used in a standard
chromium release assay with AKR/Gross MuLV-specific CTL raised by B.GV tumor priming and either AKR.H-2b.SL1 [A] or E?G2 [B] tumor
restimulation. A is a representative experiment while B depicts the averaged data of three other independent experiments. Target cell spontaneous
release values ranged from 16 to 38%. These data were also analyzed for lytic units [LU]. The lysis curves corresponded to the following: (A) SC.Kb
cells infected with AKR623, 57 LU/106 cells; SC.Kb cells infected with AKR623/7 LTR, 41 LU/106 cells; (B) SC.Kb cells infected with AKR623, 22 LU/
106 cells; SC.Kb cells infected with AKR623/7 LTR, 4 LU/106 cells. In both A and B, the lysis of SC.Kb and SC.Kb cells infected with AK7 corresponds
to less than 1 LU/106 cells.
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FIG. 6. The CTL restriction element, H-2Kb, and the viral envelope proteins gp70 and p15TM are expressed either equivalently or at somewhat
greater levels in SC.Kb cells infected with the AK7 virus in comparison to cells infected by the AKR623 virus. Cell surface antigen expression was
analyzed by indirect immunofluoresence as described under Materials and Methods. The results are displayed as the difference of the total mean
fluoresence intensity [TMFI] values of the indicated experimental mAbs from which the background fluoresence TMFI of the matched isotype control
was subtracted.
Collectively, these experiments suggest that because ever, examining the relative antiviral CTL susceptibilities
of AKR623 versus AK7-infected SC.Kb cells have demon-the AK7-derived transcriptional enhancer does not fully
abrogate the ability of AKR623/7 LTR-infected cells to be strated that when the infection by AK7 was allowed to
proceed until the cell surface viral antigen displayrecognized by AKR/Gross MuLV-specific CTL, the pres-
ence of only one copy of the transcriptional enhancer reached steady-state and equivalent levels as AKR623-
infected SC.Kb cells, that AK7 was still inefficiently recog-was sufficient for the processing and presentation of
at least some of the KSPWFTTL CTL determinant. The nized by AKR/Gross MuLV-specific CTL [White et al.,
1993]. Indeed, relative to the present studies, Fig. 6observation that the AKR623/7 LTR chimeric was gener-
ally not as efficiently recognized as AKR623-infected clearly demonstrates that by flow cytometric analysis,
AK7 causes the accumulation of at least as much of thecells, however, indicates that the introduction of the AK7-
derived enhancer had a negative impact upon the ability viral proteins env, gp70, and p15TM when compared to
AKR623. Rather than quantitatively lower overall levelsto be recognized by AKR/Gross MuLV-specific CTL. Con-
sequently, these data support the hypothesis that the of expression of either the env or p15TM proteins as the
source for peptide 12, it is thus conceivable that thedeficiency of one copy of the AK7-derived transcriptional
enhancer is an important, albeit incomplete, explanation inefficient recognition of AK7-infected SC.Kb cells by AKR/
Gross MuLV-specific CTL is partly due to either a slowerfor the inefficient levels of recognition of AK7-infected
cells by AKR/Gross MuLV-specific CTL. rate of viral envelope translation by AK7-infected cells
and/or a slower rate of degradation that would result inConsistent with the idea that multiple enhancers may
be more effective at increasing transcription rates than lower KSPWFTTL production. Implicit in this explanation
is the concept that the mature p15TM protein or envelopea single enhancer copy [Lovmand et al., 1990; Graves et
al., 1985; Boral et al., 1989; Hallberg and Grundstrom, precursor that is destined to become cell surface and
virion-associated gp70/p15TM is not the only, or perhaps1988; Losardo et al., 1989; Etzerodt et al., 1990], it was
also observed that infection by AK7 spreads more slowly the primary, source for peptide 12. Whatever the identity
of the important polypeptide precursor for peptide 12,than AKR623 [White et al., 1993]. Previous studies, how-
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